Wear it pink on 24 October This October, wear pink and raise money to help fund life-changing breast cancer research and support.
Book a Public Health Talk Raise awareness of breast cancer in your local community or network by booking a free online or in-person talk.
Home About us Media Breast Cancer Now media statements 207 results Responding to the NICE decision to approve olaparib (Lynparza) for certain people with locally advanced or secondary breast cancer who have inherited an altered BRCA gene. 09 Jan 2025 2 min read We respond to new University of Oxford research highlighting the potential of the TriOx test to improve early cancer detection 08 Jan 2025 1 min read Breast Cancer Now responds to early diagnosis in England reaching highest level ever 02 Jan 2025 1 min read Breast Cancer Now 's response to NICE final decision on elacestrant (Korserdu) 19 Dec 2024 1 min read We respond to report revealing more than one in four premature deaths in UK 'will be due to cancer by 2050' 21 Nov 2024 1 min read We respond to NICE guidance to not recommend Enhertu for HER2-low secondary breast cancer remaining unchanged 19 Nov 2024 1 min read We respond to the National Cancer Medicines Advisory Group in Scotland supporting use of anastrozole, tamoxifen and raloxifene to reduce risk of breast cancer 24 Oct 2024 1 min read We respond to new research that suggests women who use a contraceptive coil may have a slightly higher risk of developing breast cancer 17 Oct 2024 1 min read We respond to news that a blood test could detect 12 most common cancers before symptoms develop 08 Oct 2024 2 min read We respond to NICE provisional decision to not recommend elacestrant in England 01 Oct 2024 1 min read We respond to NICE Board decision to not make changes to severity modifier 25 Sept 2024 2 min read Our response to new analysis from Cancer Research UK revealing more than 300,000 cancer patients face delays over the next five years 20 Sept 2024 1 min read Previous 1 ... 4 ... 18 Next
Responding to the NICE decision to approve olaparib (Lynparza) for certain people with locally advanced or secondary breast cancer who have inherited an altered BRCA gene. 09 Jan 2025 2 min read
We respond to new University of Oxford research highlighting the potential of the TriOx test to improve early cancer detection 08 Jan 2025 1 min read
Breast Cancer Now responds to early diagnosis in England reaching highest level ever 02 Jan 2025 1 min read
Breast Cancer Now 's response to NICE final decision on elacestrant (Korserdu) 19 Dec 2024 1 min read
We respond to report revealing more than one in four premature deaths in UK 'will be due to cancer by 2050' 21 Nov 2024 1 min read
We respond to NICE guidance to not recommend Enhertu for HER2-low secondary breast cancer remaining unchanged 19 Nov 2024 1 min read
We respond to the National Cancer Medicines Advisory Group in Scotland supporting use of anastrozole, tamoxifen and raloxifene to reduce risk of breast cancer 24 Oct 2024 1 min read
We respond to new research that suggests women who use a contraceptive coil may have a slightly higher risk of developing breast cancer 17 Oct 2024 1 min read
We respond to news that a blood test could detect 12 most common cancers before symptoms develop 08 Oct 2024 2 min read
We respond to NICE provisional decision to not recommend elacestrant in England 01 Oct 2024 1 min read
Our response to new analysis from Cancer Research UK revealing more than 300,000 cancer patients face delays over the next five years 20 Sept 2024 1 min read
